心力衰竭生化标志物研究进展  

Research Progress in Biochemical Markers of Heart Failure

作　　者：雷永兰 敖茂成 何文凤[2] 

机构地区：[1]攀枝花市中心医院检验科,四川攀枝花617000 [2]川北医学院附属医院心血管内科,四川南充637000

出　　处：《心血管病学进展》2013年第4期586-589,共4页Advances in Cardiovascular Diseases

摘　　要：心力衰竭是大多数心血管疾病的最终归宿,也是其最主要的死亡原因。虽然其处置的重点已经转向早期干预和改善生活质量,以及降低病死率,但缺乏特异的临床表现仍阻碍了心力衰竭患者的早期诊断和治疗。生化标志物的研究在心力衰竭患者的早期诊断、治疗以及预后中扮演了重要角色。现就目前心力衰竭生化标记物的研究进展做一综述。Heart failure is the final destination of the majority cardiovascular disease,furthermore which is the main cause of the death.The focus of the disposal has been shifted to early intervention,improve quality of life and reduce mortality,but the lack of specific clinical manifestations still hamper the early diagnosis and treatment of heart failure patients.Biochemical markers plays a very important role in early diagnosis,treatment and prognosis in patient with heart failure.In this paper,the current biochemical markers of heart failure research progress has been reviewed.

关 键 词：心力衰竭 标记物 研究进展 

分 类 号：R541.6[医药卫生—心血管疾病]